Susan Downes
Susan Downes
Verified email at
Cited by
Cited by
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial
U Chakravarthy, SP Harding, CA Rogers, SM Downes, AJ Lotery, ...
Ophthalmology 119 (7), 1399-1411, 2012
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
RE MacLaren, M Groppe, AR Barnard, CL Cottriall, T Tolmachova, ...
The Lancet 383 (9923), 1129-1137, 2014
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
U Chakravarthy, SP Harding, CA Rogers, SM Downes, AJ Lotery, ...
The Lancet 382 (9900), 1258-1267, 2013
A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21. 1
AM Payne, SM Downes, DAR Bessant, R Taylor, GE Holder, MJ Warren, ...
Human molecular genetics 7 (2), 273-277, 1998
Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa
AE Davidson, ID Millar, JE Urquhart, R Burgess-Mullan, Y Shweikh, ...
The American Journal of Human Genetics 85 (5), 581-592, 2009
Visual acuity after retinal gene therapy for choroideremia
TL Edwards, JK Jolly, M Groppe, AR Barnard, CL Cottriall, T Tolmachova, ...
New England Journal of Medicine 374 (20), 1996-1998, 2016
Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy
PH Scanlon, R Malhotra, RH Greenwood, SJ Aldington, C Foy, M Flatman, ...
British journal of ophthalmology 87 (10), 1258-1263, 2003
Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study
SM Downes, IR Hambleton, EL Chuang, N Lois, GR Serjeant, AC Bird
Ophthalmology 112 (11), 1869-1875, 2005
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder
AJ Abrams, RB Hufnagel, A Rebelo, C Zanna, N Patel, MA Gonzalez, ...
Nature genetics 47 (8), 926-932, 2015
Next-generation sequencing (NGS) as a diagnostic tool for retinal degeneration reveals a much higher detection rate in early-onset disease
ME Shanks, SM Downes, RR Copley, S Lise, J Broxholme, KAZ Hudspith, ...
European journal of human genetics 21 (3), 274-280, 2013
RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections
I Zito, SM Downes, RJ Patel, ME Cheetham, ND Ebenezer, SA Jenkins, ...
Journal of medical genetics 40 (8), 609-615, 2003
Hydroxychloroquine retinopathy
IH Yusuf, S Sharma, R Luqmani, SM Downes
Eye 31 (6), 828-845, 2017
Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1
SM Downes, GE Holder, FW Fitzke, AM Payne, MJ Warren, ...
Archives of ophthalmology 119 (1), 96-105, 2001
Autosomal dominant cone–rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclase
K Gregory-Evans, RE Kelsell, CY Gregory-Evans, SM Downes, FW Fitzke, ...
Ophthalmology 107 (1), 55-61, 2000
Blue light–filtering intraocular lenses: Review of potential benefits and side effects
FM Cuthbertson, SN Peirson, K Wulff, RG Foster, SM Downes
Journal of Cataract & Refractive Surgery 35 (7), 1281-1297, 2009
Central serous chorioretinopathy: towards an evidence-based treatment guideline
TJ Van Rijssen, EH Van Dijk, S Yzer, K Ohno-Matsui, JEE Keunen, ...
Progress in retinal and eye research 73, 100770, 2019
A depth-based head-mounted visual display to aid navigation in partially sighted individuals
SL Hicks, I Wilson, L Muhammed, J Worsfold, SM Downes, C Kennard
PloS one 8 (7), e67695, 2013
Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
K Xue, JK Jolly, AR Barnard, A Rudenko, AP Salvetti, MI Patrício, ...
Nature medicine 24 (10), 1507-1512, 2018
Mutations in REEP6 cause autosomal-recessive retinitis pigmentosa
G Arno, SA Agrawal, A Eblimit, J Bellingham, M Xu, F Wang, C Chakarova, ...
The American Journal of Human Genetics 99 (6), 1305-1315, 2016
Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial
EHC van Dijk, S Fauser, MB Breukink, R Blanco-Garavito, ...
Ophthalmology 125 (10), 1547-1555, 2018
The system can't perform the operation now. Try again later.
Articles 1–20